Published in

Springer (part of Springer Nature), Clinical Research in Cardiology, 5(100), p. 403-411

DOI: 10.1007/s00392-010-0258-z

Links

Tools

Export citation

Search in Google Scholar

Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients

Journal article published in 2010 by Giuseppe Biondi-Zoccai, Giuseppe Biondi Zoccai, Imad Sheiban, Claudio Moretti, Tullio Palmerini, Antonio Marzocchi, Davide Capodanno ORCID, Corrado Tamburino, Massimo Margheri, Giuseppe Vecchi, Giuseppe Sangiorgi ORCID, Andrea Santarelli, Antonio L. Bartorelli, Carlo Briguori, Luigi Vignali and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background: Despite the well-known prognostic impact of systolic dysfunction in unselected patients undergoing percutaneous coronary intervention (PCI), limited data are available on its current predictive role after PCI for unprotected left main disease (ULM). We thus appraised the prognostic role of left ventricular ejection fraction (LVEF) in patients undergoing PCI for ULM with drug-eluting stents (DES). Methods: Consecutive eligible subjects were retrospectively enrolled in a national registry. Patients were divided into three groups: LVEF 45%. Relevant baseline and outcome data were compared with bivariate and multivariable tests. Results: A total of 975 subjects was included (LVEF 45%: 721). Patients with LVEF